BBIO logo

BridgeBio Pharma (BBIO) Cash From Investing

Annual CFI

$54.03 M
-$399.11 M-88.08%

December 31, 2023

Summary

Performance

1-Year Change

-88.08%

3-Year Change

+201.96%

5-Year Change

+356.86%

15-Year Change

+11745.04%

BBIO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.03%
BBIO annual cash flow from investing activities is higher than 89.03% of companies in Healthcare sector

High & Low

All-time High

$453.15 M
BBIO annual cash flow from investing activities is currently -88.08% below its historical high of $453.15 million

3-Year Low

-$200.83 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BBIO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 21, 2025
BBIO next annual earnings announcement is scheduled for Feb 21, 2025

OtherBBIOcash flowmetrics:

Annual CFF

$451.54 M
BBIO annual cash flow from financing activities is $451.54 million

Annual CFO

-$527.72 M
BBIO annual cash flow from operations is -$527.72 million

Annual FCF

-$529.03 M
BBIO annual free cash flow is -$529.03 million

Annual CAPEX

$1.31 M
BBIO annual capital expenditures is $1.31 million

Quarterly CFI

$38.23 M
+$35.19 M+1157.85%

September 30, 2024

Summary

Performance

3-Month Change

+1157.85%

1-Year Change

+58018.18%

3-Year Change

+58018.18%

5-Year Change

+58018.18%

BBIO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.78%
BBIO quarterly cash flow from investing activities is higher than 93.78% of companies in Healthcare sector

High & Low

All-time High

$149.70 M
BBIO quarterly cash flow from investing activities is currently -74.47% below its historical high of $149.70 million

3-Year Low

-$66.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BBIO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
BBIO next earnings announcement is scheduled for Feb 21, 2025

OtherBBIOcash flowmetrics:

Quarterly CFF

$707.00 K
BBIO quarterly cash flow from financing activities is $707.00 thousand

Quarterly CFO

-$180.57 M
BBIO quarterly cash flow from operations is -$180.57 million

Quarterly FCF

-$182.30 M
BBIO quarterly free cash flow is -$182.30 million

Quarterly CAPEX

$1.73 M
BBIO quarterly capital expenditures is $1.73 million

TTM CFI

$63.95 M
+$544.00 K+0.86%

September 30, 2024

Summary

Performance

3-Month Change

+0.86%

1-Year Change

+18.36%

3-Year Change

+18.36%

5-Year Change

+18.36%

BBIO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

91.86%
BBIO TTM cash flow from investing activities is higher than 91.86% of companies in Healthcare sector

High & Low

All-time High

$456.98 M
BBIO TTM cash flow from investing activities is currently -86.01% below its historical high of $456.98 million

3-Year Low

-$200.83 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
BBIO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 21, 2025
BBIO next earnings announcement is scheduled for Feb 21, 2025

OtherBBIOcash flowmetrics:

TTM CFF

$270.00 M
BBIO TTM cash flow from financing activities is $270.00 million

TTM CFO

-$450.22 M
BBIO TTM cash flow from operations is -$450.22 million

TTM FCF

-$456.32 M
BBIO TTM free cash flow is -$456.32 million

TTM CAPEX

$6.11 M
BBIO TTM capital expenditures is $6.11 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BBIO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-88.1%+10000.0%+18.4%
3 y3 years+202.0%+10000.0%+18.4%
5 y5 years+356.9%+10000.0%+18.4%

BBIO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-88.1%+126.9%-74.5%>+9999.0%-86.0%+131.8%
5 y5-year-88.1%+124.9%-74.5%+113.5%-86.0%+117.1%
alltimeall time-88.1%+124.9%-74.5%+113.5%-86.0%+117.1%

BridgeBio Pharma Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$38.23 M(+1157.8%)
$63.95 M(+0.9%)
Jun 2024
-
$3.04 M(-86.6%)
$63.41 M(-1.7%)
Mar 2024
-
$22.75 M(<-9900.0%)
$64.49 M(+19.3%)
Dec 2023
$54.03 M(-88.1%)
-$66.00 K(-100.2%)
$54.03 M(-25.0%)
Sep 2023
-
$37.68 M(+814.8%)
$72.06 M(-60.2%)
Jun 2023
-
$4.12 M(-66.5%)
$181.24 M(-44.5%)
Mar 2023
-
$12.30 M(-31.5%)
$326.82 M(-27.9%)
Dec 2022
$453.15 M(-325.6%)
$17.96 M(-87.8%)
$453.15 M(-0.8%)
Sep 2022
-
$146.86 M(-1.9%)
$456.98 M(+23.8%)
Jun 2022
-
$149.70 M(+8.0%)
$369.09 M(+67.9%)
Mar 2022
-
$138.62 M(+535.9%)
$219.85 M(-209.5%)
Dec 2021
-$200.83 M
$21.80 M(-63.0%)
-$200.83 M(+43.8%)
Sep 2021
-
$58.97 M(>+9900.0%)
-$139.61 M(-42.7%)
Jun 2021
-
$458.00 K(-100.2%)
-$243.63 M(-34.7%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$282.05 M(-439.7%)
-$373.07 M(+604.0%)
Dec 2020
-$52.99 M(-75.6%)
$83.02 M(-284.3%)
-$52.99 M(-65.3%)
Sep 2020
-
-$45.05 M(-65.1%)
-$152.91 M(-49.9%)
Jun 2020
-
-$128.98 M(-439.2%)
-$305.20 M(+72.6%)
Mar 2020
-
$38.02 M(-325.0%)
-$176.80 M(-18.6%)
Dec 2019
-$217.25 M(+932.8%)
-$16.90 M(-91.4%)
-$217.25 M(+6.5%)
Sep 2019
-
-$197.34 M(>+9900.0%)
-$203.95 M(+2727.2%)
Jun 2019
-
-$583.00 K(-76.0%)
-$7.21 M(-12.9%)
Mar 2019
-
-$2.43 M(-32.6%)
-$8.29 M(-60.6%)
Dec 2018
-$21.04 M(+4433.6%)
-$3.60 M(+494.9%)
-$21.04 M(+20.6%)
Sep 2018
-
-$605.00 K(-63.4%)
-$17.44 M(+3.6%)
Jun 2018
-
-$1.66 M(-89.1%)
-$16.83 M(+10.9%)
Mar 2018
-
-$15.18 M
-$15.18 M
Dec 2017
-$464.00 K
-
-

FAQ

  • What is BridgeBio Pharma annual cash flow from investing activities?
  • What is the all time high annual CFI for BridgeBio Pharma?
  • What is BridgeBio Pharma annual CFI year-on-year change?
  • What is BridgeBio Pharma quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for BridgeBio Pharma?
  • What is BridgeBio Pharma quarterly CFI year-on-year change?
  • What is BridgeBio Pharma TTM cash flow from investing activities?
  • What is the all time high TTM CFI for BridgeBio Pharma?
  • What is BridgeBio Pharma TTM CFI year-on-year change?

What is BridgeBio Pharma annual cash flow from investing activities?

The current annual CFI of BBIO is $54.03 M

What is the all time high annual CFI for BridgeBio Pharma?

BridgeBio Pharma all-time high annual cash flow from investing activities is $453.15 M

What is BridgeBio Pharma annual CFI year-on-year change?

Over the past year, BBIO annual cash flow from investing activities has changed by -$399.11 M (-88.08%)

What is BridgeBio Pharma quarterly cash flow from investing activities?

The current quarterly CFI of BBIO is $38.23 M

What is the all time high quarterly CFI for BridgeBio Pharma?

BridgeBio Pharma all-time high quarterly cash flow from investing activities is $149.70 M

What is BridgeBio Pharma quarterly CFI year-on-year change?

Over the past year, BBIO quarterly cash flow from investing activities has changed by +$38.29 M (+58018.18%)

What is BridgeBio Pharma TTM cash flow from investing activities?

The current TTM CFI of BBIO is $63.95 M

What is the all time high TTM CFI for BridgeBio Pharma?

BridgeBio Pharma all-time high TTM cash flow from investing activities is $456.98 M

What is BridgeBio Pharma TTM CFI year-on-year change?

Over the past year, BBIO TTM cash flow from investing activities has changed by +$9.92 M (+18.36%)